Skip to content

Transcutaneous electrical acupoint stimulation combined with transcutaneous auricular vagus nerve stimulation the treatment of uterine contraction pain after cesarean section

Observation on the clinical efficacy of transcutaneous electrical acupoint stimulation combined with transcutaneous auricular vagus nerve stimulation in treating uterine contraction pain after cesarean section

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000946
Enrollment
Unknown
Registered
2026-04-12
Start date
2026-04-20
Completion date
Unknown
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postpartum uterine contraction pain

Interventions

A group:TEAS+taVNS
B group:TEAS+sham taVNS
C group:sham TEAS+taVNS
D group:sham TEAS+sham taVNS

Sponsors

School of Second Clinical Medicine, Yunnan University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1: Cesarean section 2: Age = 18 years old 3: Gestational weeks 37 - 42 weeks 4: Single fetus, planned breastfeeding 5: Undergoing epidural anesthesia 6: American Society of Anesthesiologists (ASA) classification II or III 7: Capable of cooperating to complete the clinical study and signing the informed consent form

Exclusion criteria

Exclusion criteria: 1: Severe pregnancy-related complications or postpartum complications 2: Previous uterine or pelvic diseases, such as uterine adenomyosis, pelvic inflammatory diseases, etc. 3: Presence of severe psychological disorders or mental illnesses, such as mania, schizophrenia, etc. 4: Long-term use of analgesic drugs 5: Skin damage, ulcers, sensory disorders at the treatment site 6: Existing equipment that may affect the TEAS/taVNS device or be affected by the TEAS/taVNS device 7: Allergic to the equipment in the study and the rescue analgesic drugs 8: Recently received similar treatment or is participating in other studies

Design outcomes

Primary

MeasureTime frame
The proportion of cases with Visual Analog Scale (VAS) score for uterine contractions = 4;

Secondary

MeasureTime frame
Proportion of patients with uterine contraction pain VAS score = 4 at other time points;The frequency, duration, number of occurrences with pain intensity = 4 on the VAS scale, and peak values of uterine contractions during the use of oxytocin.;The frequency, duration, number of occurrences with VAS = 4, and peak value of uterine contractions pain episodes;The time when the contractions pain completely disappears;Wound pain and other types of pain;Lactation yield;The time of first lactation, the number of breastfeeding sessions, the peak intensity of contractions during breastfeeding;Amount of vaginal bleeding;Depression score;Anxiety score;Sleep score;Dosage of analgesic drugs;ECG (electrocardio);

Countries

China

Contacts

Public ContactTaipin Guo

Yunnan University of Chinese Medicine

gtphncs@126.com+86 184 8727 2658

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: May 1, 2026